medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2010, Number 591

<< Back Next >>

Rev Med Cos Cen 2010; 67 (591)

Esclerosis lateral amiotrofica

Fallas SM

Language: Spanish
References: 20
Page: 89-92
PDF size: 207.93 Kb.


ABSTRACT

Amyotrophic lateral sclerosis is a progressive neurologic disease which cause is still unknown. The disease attacks the voluntary muscles and most people die from respiratory failure, usually within 3 to 5 years from the onset of symptoms. Even though there is no effective treatment, there has been an improvement in the symptoms and quality of life of patients due to technological advancements. This article presents a review of the most important aspects of this disease.


REFERENCES

  1. Boilee S, Vande V, Cleveland D: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006; 52 (1): 39-59.

  2. Brooks B, Miller R, Swash M et al: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Motor Neuron Disord. 2000; 1(5): 293-299.

  3. Bruijn L, Miller T, Cleveland D: Unraveling the mechanism involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723-749.

  4. Chen Y, Bennet C, Huyhn H: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis. Am j Hum Genet. 2004; 73(2):390-396.

  5. Greenway M, Andersen P, Russ C: ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis. Nat Genet. 2006; 38(4):411-413.

  6. Hand C, Khoris J, Salachas F: A novel locus for familial amyotrophic lateral sclerosis on chromosome 18q. Am J Hum Genet. 2002; 70(1):251-256.

  7. Hosler B, Siddique T, Sapp P: Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia. JAMA. 2000; 284(13):1664-1669.

  8. Houseman G: Symptom Management of the Patient with Amyotrophic Lateral Sclerosis. Journal of Hospice and Palliative Nursing. 2008; 10(4):214-215.

  9. Kurt A, Nijboer F, Matuz T et al: Depression and anxiety in individual with amyotrophic lateral sclerosis: epidemiology and management. CNS drugs. 2007; 21(4):279-291.

  10. Kwong L, Neumann M, Sampathu D et al: The neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration motor neuron disease. Acta Neuropathol. 2007; 114:63-70.

  11. Lomen C: Amyotrophic lateral sclerosis from bench to bedside. Semin Neurol. 2008; 28(2):205-211.

  12. Mackenzie I, Bigio E, Ince P: Pathological TDP 43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007; 61(5):427-434.

  13. Miller R, Rosenberg J, Gelinas D: Practice Parameter: the care of the patient with amyotrophic lateral sclerosis. Neurology. 1999; 2(7) 1311-1323.

  14. Morita M, al. Chalabi A, Andersen P: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology . 2006; 66(6):839-844.

  15. Murphy J, Henry R, Lomen-Hoerth C: Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol, 2007; 64(3):330-334.

  16. Neary D, Snowden J, Mann D: Cognitive change in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci. 2000; 180(1-2):15-20.

  17. Rabkin J, Albert S, Del Bene M: Prevalence of depressive disorders and change over the time in late stage ALS. Neurology. 2005; 65(1):62-67.

  18. Rowland P. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998; 160(1):s6-s24.

  19. Ruddy D, Parton M: Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Genet. 2004; 74(6):1128-1135.

  20. Sapp P, Hosler B, McKenna Yasek M: Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet. 2003; 73(2):390-396.




2020     |     www.medigraphic.com